We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
+33.33%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$1.76B
AUM Growth
+$349M
Cap. Flow
+$63.3M
Cap. Flow %
3.6%
Top 10 Hldgs %
46.56%
Holding
242
New
48
Increased
31
Reduced
35
Closed
71

Top Buys

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$45.5M
2
RDUS
Radius Health, Inc.
RDUS
+$27.1M
3
EVH icon
Evolent Health
EVH
+$21.8M
4
LJPC
La Jolla Pharmaceutical Company
LJPC
+$20.9M
5
ANAB icon
AnaptysBio
ANAB
+$20.5M

Top Sells

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$72.8M
2
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$39.5M
3
SRPT icon
Sarepta Therapeutics
SRPT
+$30.9M
4
CLCD
CoLucid Pharmaceuticals, Inc.
CLCD
+$23.3M
5
ACOR
Acorda Therapeutics
ACOR
+$13.5M

Sector Composition

Rank Sector Weight
1 Healthcare 98.25%
2 Miscellaneous 1.35%
3 Consumer Staples 0.26%
4 Consumer Discretionary 0.06%
5 Industrials 0.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HSKA
101
DELISTED
Heska Corp
HSKA
$661K 0.04%
+6,300
New +$539K
OSUR icon
102
OraSure Technologies
OSUR
$239M
$609K 0.03%
+47,125
New +$487K
ILMN icon
103
Illumina
ILMN
$33.6B
$597K 0.03%
+3,598
New +$567K
AKAO
104
DELISTED
Achaogen Inc
AKAO
$593K 0.03%
+23,496
New +$483K
TARA icon
105
Protara Therapeutics
TARA
$222M
$585K 0.03%
8,353
– –
RDUS
106
PUT
DELISTED
Radius Health, Inc.
RDUS
$570K 0.03%
+9,800
New +$411K
HRC
107
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$560K 0.03%
7,930
– –
MASI
108
DELISTED
Masimo
MASI
$554K 0.03%
+5,945
New +$489K
CNC icon
109
Centene
CNC
$33.4B
$551K 0.03%
+15,452
New +$517K
MDRX
110
DELISTED
Veradigm Inc. Common Stock
MDRX
$545K 0.03%
+42,955
New +$509K
PRAH
111
DELISTED
PRA Health Sciences, Inc.
PRAH
$542K 0.03%
+8,308
New +$489K
HMSY
112
DELISTED
HMS Holdings Corp.
HMSY
$540K 0.03%
+26,553
New +$490K
MCK icon
113
McKesson
MCK
$105B
$534K 0.03%
3,601
+523
+17% +$76.6K
CBM
114
DELISTED
Cambrex Corporation
CBM
$524K 0.03%
+9,515
New +$508K
PAHC icon
115
Phibro Animal Health
PAHC
$1.42B
$517K 0.03%
+18,382
New +$519K
NXGN
116
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$516K 0.03%
+33,875
New +$499K
ELV icon
117
Elevance Health
ELV
$90.6B
$510K 0.03%
+3,081
New +$490K
VNDA icon
118
Vanda Pharmaceuticals
VNDA
$302M
$507K 0.03%
+36,232
New +$516K
CUTR
119
DELISTED
Cutera, Inc.
CUTR
$496K 0.03%
+23,981
New +$473K
RACE icon
120
Ferrari
RACE
$71.5B
$461K 0.03%
6,200
– –
AKBA icon
121
Akebia Therapeutics
AKBA
$250M
$457K 0.03%
49,624
-487,632
-91% -$4.76M
BLUE
122
DELISTED
bluebird bio
BLUE
$422K 0.02%
+359
New +$366K
ONSIW
123
DELISTED
Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
$370K 0.02%
462,500
-193,882
-30% -$82.2K
CYTO
124
DELISTED
Altamira Therapeutics Ltd
CYTO
$368K 0.02%
+5
New +$401K
QHC
125
DELISTED
Quorum Health Corporation
QHC
$275K 0.02%
50,604
-50,000
-50% -$407K
3 4
5
6 7

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Perceptive Advisors held 242 positions worth $1.76B, up 25% from $1.41B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Perceptive Advisors deployed $63.3M of net new capital in Q1 2017, opening 48 new positions and adding to 31 existing holdings. Its largest new stake was AnaptysBio: 881,957 shares worth $24.5M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 98% a quarter earlier, followed by Miscellaneous and Consumer Staples.

On the sell side, the largest reduction was TESARO, Inc., an estimated $72.8M trimmed.

  • Perceptive Advisors's largest Q1 2017 buy was AnaptysBio: 881,957 shares worth $24.5M.
  • Perceptive Advisors added most to Alnylam Pharmaceuticals in Q1 2017, an estimated $45.5M increase.
  • Perceptive Advisors's biggest Q1 2017 reduction was TESARO, Inc., cutting an estimated $72.8M.
  • Perceptive Advisors fully exited Eagle Pharmaceuticals, Inc. in Q1 2017, selling an estimated $39.5M.
  • Perceptive Advisors's ten largest holdings make up 47% of its $1.76B portfolio in Q1 2017.
  • Perceptive Advisors opened 48 new positions and closed 71 in Q1 2017.
  • Perceptive Advisors's portfolio value rose 25% quarter-over-quarter to $1.76B.

Based on Perceptive Advisors's 13F filing for Q1 2017, filed 15 May 2017.